Auckland, Northland and parts of the Waikato are now operating under Level 3 restrictions with Click & Collect services now available at the majority of our stores. All stores outside of Level 3 areas remain open for in-store customers. Online orders will be available for all customers with some delays due to courier backlogs and lockdown procedures.
Thalassemia -


Causes, Treatment Options & Long-Term Health Outcomes


Or 4 payments of $127.50 with

delivery message Free delivery for orders over $49.99

Add to Favourites
Sourced from our Overseas Supplier
Delivered in 10 - 20 days
Available for Click and Collect
Thalassemia is one of the most common genetic disorders worldwide and presents major public health and social challenges in areas of high incidence. The frequency of this disorder varies considerably with geographic locations and racial groups. Thalassemia refers to a group of inherited hemolytic anemia disorders that involve defects in the synthesis of hemoglobin alpha- or ss-polypeptide chains. It leads to decreased hemoglobin production and hypochromic microcytic anemia associated with erythrocyte dysplasia and destruction. Homozygous ss-thalassemia (also known as thalassemia major, Cooley's anemia, or Mediterranean anemia) is associated with the most severe signs and symptoms. Thalassemia major (TM) is a life-threatening condition that commonly manifests during early infancy, after which progressive pallor, severe anemia, and failure to thrive are common. Children with TM often develop feeding problems, recurrent fever, bleeding tendencies (especially epistaxis), susceptibility to infection, pathologic fractures of long bones and vertebrae, endocrine abnormalities, splenomegaly, lack of sexual maturation, and growth retardation. This book discusses cures and treatments available for thalassemia, as well as the causes and the type of long-term health outcomes it may cause.

Product code: 9781631179549

ISBN 9781631179549